Investigating new clinical modalities requires full departmental commitment and prior knowledge of existing therapies. Comparative biologic effect studies and proposed non-randomized trials can optimize patient use in Phase III investigations.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: